Home » ATRIUM BIOTECHNOLOGIES Q4 PROFIT JUMPS 78% TO $4M
ATRIUM BIOTECHNOLOGIES Q4 PROFIT JUMPS 78% TO $4M
Atrium Biotechnologies Inc. (TSX: ATB.SV) reported higher profits in the fourth quarter as the maker of specialty chemicals for the pharmaceutical, cosmetics and nutrition industries generated sharply higher revenues. The Quebec-based company said Tuesday its net earnings for the three months ended Dec. 31 rose 78 per cent to US$4.0 million or 14 cents a share, compared with US$2.3 million or 10 cents a share for the same period in 2004.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May